TerrAscend Corp. (“TerrAscend” or the “Company”), a major North American cannabis operator, has announced a significant partnership with Tyson 2.0, the cannabis brand co-founded by legendary boxer Mike Tyson. Under an exclusive licensing agreement unveiled on November 25, 2025, TerrAscend will bring Tyson 2.0 products to legal cannabis markets in Maryland and Pennsylvania — marking a strategic expansion for both companies in key East Coast states.
This collaboration blends Tyson 2.0’s brand influence and TerrAscend’s retail and manufacturing infrastructure, with products expected on dispensary shelves in early 2026. Below is a full breakdown of what the deal entails, its anticipated impact, and why it matters for cannabis consumers and the broader industry.
What the Agreement Covers
The licensing agreement gives TerrAscend the rights to manufacture and distribute a suite of Tyson 2.0 cannabis products under the Tyson 2.0 brand in Maryland and Pennsylvania, two rapidly developing cannabis markets.
In Maryland
- TerrAscend will produce and sell premium flower, vape cartridges, and edibles under the Tyson 2.0 brand.
- These will be available through The Apothecarium dispensary locations (TerrAscend’s retail arm) and other participating dispensaries in the state’s medical and adult-use market.
In Pennsylvania
- The lineup expands to include flower, vapes, concentrates, and troches (dissolvable lozenges that deliver cannabinoids).
- Products will be distributed through TerrAscend’s wholesale network as well as Apothecarium stores operating in the commonwealth.
The first Tyson 2.0 products under this exclusive deal are expected to hit dispensary shelves in early 2026, offering consumers a wider range of branded cannabis options from an internationally recognized name.
Brand Background: Tyson 2.0
Tyson 2.0 is a cannabis lifestyle and product brand co-founded by Mike Tyson, born from his personal advocacy for cannabis following his retirement from professional boxing. The brand’s mission centers on producing high-quality cannabis products and broadening access to adults who use cannabis both recreationally and therapeutically.
The partnership with TerrAscend represents a key chapter in Tyson 2.0’s ongoing national expansion. While retrospectively the brand has been present in multiple markets (including earlier distribution partnerships in states like Arizona, Maryland, Ohio, and Pennsylvania through other operators), this new licensing agreement formalizes a long-term, region-specific strategy anchored by a major multistate operator. READ MORE: PR Newswire
TerrAscend’s Strategic Role
TerrAscend is an experienced cannabis company with an integrated footprint across several U.S. and Canadian markets. It operates cultivation, processing, manufacturing, and retail assets — including The Apothecarium dispensaries, where many Tyson 2.0 products will be available.
In this agreement:
- TerrAscend leverages its manufacturing and distribution infrastructure to scale Tyson 2.0 offerings.
- The company’s existing retail channels provide an immediate route to market in both states.
- The partnership aligns with TerrAscend’s broader growth plans at a time when the East Coast cannabis market continues to expand.
Jason Wild, TerrAscend’s Executive Chairman, emphasized the shared enthusiasm for cannabis reform and quality product delivery, noting that Tyson’s commitment aligns with TerrAscend’s mission and operational focus.
Timeline and Market Context
The announcement came in late November 2025, positioning both companies to prepare for a product rollout in 2026 — a pivotal year for cannabis growth in many states.
Maryland
- Maryland recently transitioned into an operational adult-use market, with legal recreational sales underway. This creates a prime environment for new branded products like Tyson 2.0 to enter mainstream retail. (Maryland’s adult-use legalization took effect in 2023 and retail infrastructure continues expanding.)
Pennsylvania
- Pennsylvania remains a strong medical cannabis market with ongoing discussions about future adult-use reform. The inclusion of products like concentrates and troches suggests TerrAscend and Tyson 2.0 are targeting both medical consumers and adults seeking innovative formats.
Why This Partnership Matters
Branding Power Meets Operational Scale
Combining a high-profile brand like Tyson 2.0 with a scalable operator like TerrAscend creates a powerful go-to-market team:
- Brand recognition: Mike Tyson’s global name helps Tyson 2.0 stand out in a crowded cannabis market.
- Distribution muscle: TerrAscend’s infrastructure enables rapid production and shelf placement across dispensaries.
- Product diversity: The agreement covers a wide range of formats — from traditional flower to innovative troches — broadening appeal across consumer segments.
Expansion in Key Adult-Use and Medical Markets
Adult-use cannabis in Maryland and well-established medical programs in Pennsylvania offer fertile ground for premium brands to grow. If early adoption is strong, this partnership could set the stage for further regional or national collaborations between licensed cannabis operators and celebrity-driven brands.
Strategic Positioning Ahead of Federal Reform
Although federal cannabis reform remains uncertain and the plant remains illegal at the national level, state markets continue to expand. Deals like this one demonstrate how companies are positioning themselves to capitalize on state-level legalization trends — building brand loyalty and market share while consumers increasingly embrace diverse cannabis offerings.
Sources
- TerrAscend press release on the Tyson 2.0 licensing agreement, including product categories and state rollout plans. SITE: TerrAscend Corp.
- MarketScreener summary of TerrAscend’s announcement and product expectations for early 2026. SITE: MarketScreener
- Cannabis Equipment News reporting on the TerrAscend/Tyson 2.0 partnership details and distribution strategy. SITE: Cannabis Equipment News
Final Thoughts
TerrAscend’s exclusive licensing agreement with Tyson 2.0 marks a notable milestone in cannabis brand collaborations. With a recognized public figure behind the brand and a seasoned operator to manage production and distribution, the partnership is poised to introduce a compelling lineup of cannabis products in Maryland and Pennsylvania in 2026.
As legal markets continue to evolve, such deals may become more common — especially as brands seek differentiation and operators pursue strategic growth through high-impact partnerships.